FIELD: medicine.
SUBSTANCE: in the general blood analysis on the first day, the concentration of red blood cells (X1, 109/l), the average count of platelets (X2, fL), lymphocytes (X3,%), stab neutrophils (X4,%), concentration of conjugated bilirubin (X5, mcmol/l) are determined, in the cord blood - the concentration of CD23 (X6, 10/l), the concentration of IFN-γ (X7, pg/ml), the concentration of IL-6 (X8, pg/ml). The diagnostic index (DI) is calculated using the formula: DI=K1×X1+K2×X2+K3×X3+K4×X4+K5×X5+K6×X6+K7×X7+K8×X8+const, where X1 - is the concentration of red blood cells, 109/l, X2 is the average platelet count, fL, X3 is lymphocytes, %, X4 is stab neutrophils, %, X5 is the conjugated bilirubin concentration, mcmol/l, X6 is the concentration of CD23, 10/l, X7 is the concentration of IFN-γ, pg/ml, X8 is the concentration of IL-6, pg/ml, K1=2.311; K2=-1.106; K3=-0.104; K4=-0.431; K5=-0.437; K6=-7.751; K7=-0.236; K8=0.015; const=8.335. With DI more than 0 a conclusion is made about possible vaccination against tuberculosis in the maternity home, and with DI less than 0, medical withdrawal from vaccination against tuberculosis in the maternity home is predicted.
EFFECT: application of this invention can reduce postvaccinal immune responses and increase the effectiveness of vaccinations conducted by optimisation of the timing of primary vaccination of children from perinatal risk groups and personalized approach to immunization.
6 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING THE DEVELOPMENT OF HYPERBILIRUBINEMIA IN FULL-TERM NEWBORNS BORN BY THE CESAREAN SECTION OPERATION METHOD | 2019 |
|
RU2711107C1 |
METHOD FOR PREDICTING RISK OF ISCHEMIC DAMAGE TO CENTRAL NERVOUS SYSTEM OF MODERATE AND SEVERE SEVERITY IN FULL-TERM NEWBORNS BORN BY CAESAREAN SECTION | 2020 |
|
RU2753820C1 |
METHOD OF PREDICTING BRONCHOPULMONARY DYSPLASIA DEVELOPMENT IN PREMATURE INFANTS WITH EXTREME LOW BODY WEIGHT AT BIRTH | 2012 |
|
RU2514013C2 |
METHOD FOR SETTING EARLY STAGE CYTOMEGALOVIRUS INFECTION DIAGNOSIS IN NEWBORNS | 2006 |
|
RU2317550C1 |
METHOD OF PREDICTING DEVELOPMENT OF EARLY NEONATAL SEPSIS IN NEWBORNS WHOSE MOTHERS HAD COVID-19 DURING PREGNANCY | 2023 |
|
RU2813809C1 |
METHOD FOR PREDICTING THE RISK OF DEVELOPING UNFAVOURABLE MATERNAL OUTCOMES DURING PREGNANCY, CHILDBIRTH AND THE POSTPARTUM PERIOD | 2023 |
|
RU2803129C1 |
METHOD FOR PREDICTION OF RISK OF PERINATAL CENTRAL NERVOUS SYSTEM DISORDER IN NEONATAL PERIOD IN FULL-TERM INFANTS SUFFERED BIRTH ASPHYXIA | 2011 |
|
RU2465595C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF POSTNATAL ADAPTATION PERIOD IN FULL-TERM INFANTS SUFFERED BIRTH ASPHYXIA | 2010 |
|
RU2462714C1 |
METHOD OF PREDICTING MORTALITY IN NEWBORNS WHOSE MOTHERS HAD COVID-19 DURING PREGNANCY | 2023 |
|
RU2800892C1 |
METHOD FOR EARLY DIAGNOSTICS OF NEONATAL SEPSIS | 2021 |
|
RU2755218C1 |
Authors
Dates
2018-02-15—Published
2017-07-18—Filed